137 related articles for article (PubMed ID: 23992095)
1. Statins as regulators of redox signaling in platelets.
Violi F; Pignatelli P
Antioxid Redox Signal; 2014 Mar; 20(8):1300-12. PubMed ID: 23992095
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition.
Violi F; Carnevale R; Pastori D; Pignatelli P
Trends Cardiovasc Med; 2014 May; 24(4):142-8. PubMed ID: 24263084
[TBL] [Abstract][Full Text] [Related]
3. Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets.
Violi F; Pastori D; Carnevale R; Pignatelli P
Curr Pharm Des; 2015; 21(41):5945-50. PubMed ID: 26510431
[TBL] [Abstract][Full Text] [Related]
4. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
[TBL] [Abstract][Full Text] [Related]
5. The antithrombotic effects of statins.
Owens AP; Mackman N
Annu Rev Med; 2014; 65():433-45. PubMed ID: 24422578
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
Pignatelli P; Carnevale R; Di Santo S; Bartimoccia S; Nocella C; Vicario T; Loffredo L; Angelico F; Violi F
Biochem Pharmacol; 2012 Dec; 84(12):1635-42. PubMed ID: 23022230
[TBL] [Abstract][Full Text] [Related]
7. Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell.
Morotti A; Barale C; Melchionda E; Russo I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232746
[TBL] [Abstract][Full Text] [Related]
8. Platelet oxidative stress and thrombosis.
Violi F; Pignatelli P
Thromb Res; 2012 Mar; 129(3):378-81. PubMed ID: 22209450
[TBL] [Abstract][Full Text] [Related]
9. The effect of decreasing statin's dosage on LDL-C levels after target levels achieved.
Tan TY
Acta Neurol Taiwan; 2013 Sep; 22(3):99-105. PubMed ID: 24030088
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for antiplatelet action of statins.
Puccetti L; Pasqui AL; Auteri A; Bruni F
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):121-6. PubMed ID: 15853753
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats.
Yokoyama S; Ikeda H; Haramaki N; Yasukawa H; Katoh A; Imaizumi T
J Cardiovasc Pharmacol; 2005 Apr; 45(4):375-81. PubMed ID: 15772528
[TBL] [Abstract][Full Text] [Related]
13. Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease.
Adam O; Laufs U
Antioxid Redox Signal; 2014 Mar; 20(8):1238-50. PubMed ID: 23919665
[TBL] [Abstract][Full Text] [Related]
14. Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities.
Ferroni P; Vazzana N; Riondino S; Cuccurullo C; Guadagni F; Davì G
Antioxid Redox Signal; 2012 Nov; 17(10):1447-85. PubMed ID: 22458931
[TBL] [Abstract][Full Text] [Related]
15. Platelet NOX, a novel target for anti-thrombotic treatment.
Violi F; Pignatelli P
Thromb Haemost; 2014 May; 111(5):817-23. PubMed ID: 24402688
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
[TBL] [Abstract][Full Text] [Related]
17. Statins in heart failure--With preserved and reduced ejection fraction. An update.
Tousoulis D; Oikonomou E; Siasos G; Stefanadis C
Pharmacol Ther; 2014 Jan; 141(1):79-91. PubMed ID: 24022031
[TBL] [Abstract][Full Text] [Related]
18. Redox control of platelet functions in physiology and pathophysiology.
Pietraforte D; Vona R; Marchesi A; de Jacobis IT; Villani A; Del Principe D; Straface E
Antioxid Redox Signal; 2014 Jul; 21(1):177-93. PubMed ID: 24597688
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
